120 related articles for article (PubMed ID: 21734342)
21. Immunohistochemical study of four histologic types of parotid gland pleomorphic adenoma.
Aroni K; Fotiou G; Liossi A; Bazopoulou E; Kyrkou K
J Oral Pathol Med; 1991 Jan; 20(1):37-40. PubMed ID: 1848291
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistological investigation of the histological origin and differentiation of pleomorphic adenoma of the parotid gland].
Murakami M; Makino I; Nin F; Nishiyama Y; Saitou Y; Murakami Y
Nihon Jibiinkoka Gakkai Kaiho; 1993 Aug; 96(8):1235-45. PubMed ID: 7690850
[TBL] [Abstract][Full Text] [Related]
24. Characterization of novel cell lines from pleomorphic adenomas of the parotid gland established in a collagen gel system.
Steiner MG; Kuhel WI; Carew JF; Huo J; Hoda SA; Staiano-Coico L; Schley WS
Laryngoscope; 1997 May; 107(5):654-60. PubMed ID: 9149169
[TBL] [Abstract][Full Text] [Related]
25. The role of fine needle aspiration biopsy in deep lobe parotid tumors: Comparison of preoperative cytology and postoperative histopathologic results.
Seyhun N; Doğan U; Çalış ZAB; Kaya MF; Hasçiçek SÖ; Turgut S
Am J Otolaryngol; 2021; 42(1):102590. PubMed ID: 33045535
[TBL] [Abstract][Full Text] [Related]
26. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma ex pleomorphic adenoma of the parotid gland.
Kashiwagi N; Murakami T; Chikugo T; Tomita Y; Kawano K; Nakanishi K; Mori K; Tomiyama N
Acta Radiol; 2012 Apr; 53(3):303-6. PubMed ID: 22287150
[TBL] [Abstract][Full Text] [Related]
28. Immunolocalization of alpha 2, alpha 5, and alpha 6 integrin subunits in salivary tissue and adenomas of the parotid gland.
Franchi A; Santoro R; Paglierani M; Bondi R
J Oral Pathol Med; 1994 Nov; 23(10):457-60. PubMed ID: 7861330
[TBL] [Abstract][Full Text] [Related]
29. Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors.
Sowa P; Misiolek M; Zielinski M; Mazur B; Adamczyk-Sowa M
Exp Biol Med (Maywood); 2018 May; 243(9):762-769. PubMed ID: 29763370
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of acinic cell carcinoma and secretory carcinoma of the parotid gland.
Terada T; Kawata R; Noro K; Higashino M; Nishikawa S; Haginomori SI; Kurisu Y; Kuwabara H; Hirose Y
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3461-3466. PubMed ID: 31440815
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical distribution of CD9 in parotid gland tumors.
Sakamoto K; Nakamura Y; Nakashima T
Auris Nasus Larynx; 2004 Mar; 31(1):49-55. PubMed ID: 15041054
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
33. Correlation of β-catenin, but not PIN1 and cyclin D1, overexpression with disease-free and overall survival in patients with cancer of the parotid gland.
Lill C; Schneider S; Seemann R; Kadletz L; Aumayr K; Ghanim B; Thurnher D
Head Neck; 2015 Jan; 37(1):30-6. PubMed ID: 24500803
[TBL] [Abstract][Full Text] [Related]
34. [Clinical features of accessory parotid gland tumors].
Iguchi H; Wada T; Yamamoto H; Yamada K; Matsushita N; Okamoto S; Teranishi Y; Koda Y; Kosugi Y; Yamane H
Nihon Jibiinkoka Gakkai Kaiho; 2013 Dec; 116(12):1300-7. PubMed ID: 24558945
[TBL] [Abstract][Full Text] [Related]
35. [Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].
Mann W; Beck C; Karatay MC
Laryngol Rhinol Otol (Stuttg); 1985 Mar; 64(3):133-5. PubMed ID: 2985894
[TBL] [Abstract][Full Text] [Related]
36. Brain metastasis of carcinoma ex pleomorphic adenoma of the parotid gland: case report and review of the literature.
Lau R; Fernández-Coello A; Vidal-Sarró N; Céspedes D; Camins A; Taberna M; Gabarrós A
Acta Neurochir (Wien); 2017 Mar; 159(3):459-463. PubMed ID: 28108853
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of the human oncoprotein MDM2 in benign and malignant tumors of the salivary gland.
Schlott T; Nagel H; Laskawi R; Eiffert H; Droese M
Pathobiology; 2001; 69(2):67-76. PubMed ID: 11752900
[TBL] [Abstract][Full Text] [Related]
38. LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.
Long E; Ilie M; Hofman V; Havet K; Selva E; Butori C; Lacour JP; Nelson AM; Cathomas G; Hofman P
Virchows Arch; 2009 Aug; 455(2):159-70. PubMed ID: 19484260
[TBL] [Abstract][Full Text] [Related]
39. HMTH1 induces the metastasis and recurrence of the parotid adenoma by repairing DNA damage.
Xu J; Yang ZY; Chen X; Liu X
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4363-4370. PubMed ID: 30024628
[TBL] [Abstract][Full Text] [Related]
40. Basal cell adenoma and lymphoepithelial cyst as recurrent tumors of pleomorphic adenoma of the parotid gland.
Kuratomi Y; Satoh S; Hayashida S; Inokuchi A
Auris Nasus Larynx; 2006 Mar; 33(1):97-100. PubMed ID: 16171964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
